However, a previous study confirmed that GCL2505 does not affect insulin secretion15, suggesting that GCL2505 can alleviate HFD-induced glucose intolerance by enhancing insulin sensitivity rather than by increasing insulin secretion. The gene discussed is INS; the disease is Glucose intolerance.